Geneia names Heather Lavoie its CEO

30-year industry veteran takes helm of healthcare analytics firm

Heather Lavoie, president of the healthcare analytics company Geneia, has been promoted to president and CEO, succeeding Mark Caron, who has announced his retirement effective April 6.

Lavoie has more than 30 years of experience in the healthcare industry, leading startups, health plans and provider organizations. She has directed initiatives for private and public organizations on strategy, transparency, diversification, product innovation, operations and analytics. Before joining Geneia, she co-founded and served as vice president of product development, delivery and engineering for Choicelinx Corp., a Manchester-based healthcare IT company that was sold to Cigna in 2005.

Caron called Lavoie the “heart and soul of Geneia. Since day 1, she’s been a leader at the company. I’m thrilled to entrust Geneia’s employees and its bright future to her very capable hands.”

He pointed to some of her accomplishments at the firm, which has offices in Manchester, NH, and Harrisburg, Pa.: creation of the Geneia Data Intelligence Lab; development of the company’s remote patient monitoring program and the company’s work to restore the “Joy of Medicine” to practicing physicians are among the multitude of Lavoie’s accomplishments.

During her 30+ year tenure in healthcare, Heather has led start-ups, health plans and provider organizations. She has directed initiatives for private and public organizations on strategy, transparency, diversification, product innovation, operations and analytics. Previous to Geneia, Heather co-founded and served as Vice President of Product Development, Delivery and Engineering for Choicelinx Corporation, through its successful exit to CIGNA Health Care. During her tenure, she co-authored an adverse selection actuarial model with Milliman USA, used for evaluating custom-design benefit plans.